Cargando...
Radiolabeling of HER2 specific Affibody® molecule with F-18
The presence of human epidermal growth factor type 2 (HER2) on 20–30% of human breast cancer is a prognostic indicator of more rapid disease progression and a therapeutic indicator for anti-HER2 monoclonal antibodies. Because the literature has demonstrated some discordance between primary and metas...
Gardado en:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2008
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2630254/ https://ncbi.nlm.nih.gov/pubmed/19727427 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jfluchem.2008.06.021 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|